Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 April 2008, Vol. 111, No. 8, pp. 4155-4164.
Prepublished online as a Blood First Edition Paper on February 11, 2008; DOI 10.1182/blood-2007-10-120295.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
blood-2007-10-120295v1
111/8/4155    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Chen, D.
Right arrow Articles by Dorling, A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, D.
Right arrow Articles by Dorling, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted October 26, 2007
Accepted February 1, 2008

Regenerative repair after endoluminal injury in mice with specific antagonism of protease activated receptors on CD34+ vascular progenitors

Daxin Chen, Joel M Abrahams, Leanne M Smith, John H. McVey, Robert I Lechler, and Anthony Dorling*

Department of Immunology, Imperial College London, Hammersmith Hospital, London, United Kingdom
Haemostasis and Thrombosis Unit, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Hospital, London, United Kingdom

* Corresponding author; email: a.dorling{at}imperial.ac.uk.

Tissue factor (TF) and thrombin are involved in intimal hyperplasia (IH) and remodelling following vascular injury. Because many neointimal smooth muscle cells (VSMC) derive from circulating vascular progenitors (VPs), we investigated how thrombin influences VP phenotype and function. Following wire-induced carotid artery injury in mice, the majority of circulating VP expressed TF, were capable of initiating clotting in vitro, and had protease activated receptors (PAR)-1, 2 and 4. Thrombin, through PAR-1, inhibited apoptosis and caused proliferation resulting in the outgrowth of VP co-expressing markers of activated endothelial cells and VSMC, even in the presence of growth factors. These mixed phenotype VP circulated as a minority population after injury and shared a similar phenotype with many neointimal cells. Labelled CD34+ cells, injected up to two weeks post-injury could be detected in the injured vessel wall, suggesting that continued recruitment may contribute to progressive IH. Finally, CD34+ cells incubated with thrombin prior to injection promoted florid neointimal lesions, whereas those incubated with PAR antagonists inhibited IH and promoted regenerative repair characterised by the development of a quiescent endothelium. We conclude that IH post-vascular injury is due to the direct actions of thrombin on mobilised VPs.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
Sponsor: Genentech BioOncology and and Biogen Idec
Blood Online is supported in part by
Genentech BioOncology and Biogen Idec
  Copyright © 2008 by American Society of Hematology         Online ISSN: 1528-0020